Free Trial
NYSE:HQL

Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis

Abrdn Life Sciences Investors logo
$14.65
+0.09 (+0.62%)
(As of 11/1/2024 ET)

About Abrdn Life Sciences Investors Stock (NYSE:HQL)

Key Stats

Today's Range
$14.51
$14.71
50-Day Range
$14.56
$15.57
52-Week Range
$11.62
$15.90
Volume
56,793 shs
Average Volume
93,246 shs
Market Capitalization
$400.69 million
P/E Ratio
N/A
Dividend Yield
11.33%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

Countdown to the biggest trade of my 25 yr career
Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.
See More Headlines

HQL Stock Analysis - Frequently Asked Questions

Abrdn Life Sciences Investors' stock was trading at $13.46 at the beginning of the year. Since then, HQL stock has increased by 8.8% and is now trading at $14.65.
View the best growth stocks for 2024 here
.

Abrdn Life Sciences Investors' top institutional shareholders include Allspring Global Investments Holdings LLC (1.02%), Janney Montgomery Scott LLC (0.31%), Private Advisor Group LLC (0.10%) and Wealth Enhancement Advisory Services LLC (0.06%). Insiders that own company stock include Saba Capital Management, LP, Daniel R Omstead, Kathleen Goetz, Todd Reit and Rose Dimartino.
View institutional ownership trends
.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Ex-Dividend for 9/30 Dividend
8/23/2024
Dividend Payable
9/30/2024
Today
11/02/2024
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Finance
Industry
Investment offices, not elsewhere classified
Sub-Industry
Financial Services
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$39.95 million

Miscellaneous

Free Float
24,599,000
Market Cap
$400.69 million
Optionable
Not Optionable
Beta
0.73
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NYSE:HQL) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners